Weight-loss drug stocks saw broad gains, with Arrowhead Pharmaceuticals rising more than 16%, Novo Nordisk up over 4%, and Eli Lilly and Pfizer each up more than 2%.
Weight-loss drug stocks saw broad gains, with Arrowhead Pharmaceuticals rising more than 16%, Novo Nordisk rising more than 4%, and Eli Lilly and Pfizer rising more than 2%.
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
DIA Coin: A Deep Dive into the Web3 Decentralized Data Oracle Platform and its Future Outlook
-
2
DOS Network (DOS) Project Analysis: Current Status and Future Outlook of Decentralized Oracles
-
3
Binance launches bitcoin-backed 'Lite Loan' allowing eligible users to borrow up to $1,000 in USDT
-
4
Ethereum ERC-20 Token Standard: Definition, Function, and Ecosystem Impact
-
5
Bitcoin's 30-day implied volatility index (BVIV) drops to 36%, its lowest since May 31, despite weak institutional demand and stablecoin market cap declines.
-
6
Upbit lists QUID token, supports KRW, BTC, and USDT trading pairs
-
7
BIXCPRO Token Analysis: Ethereum on-chain Asset Overview and Investment Risk Warning
-
8
Bitcoin Storage Guide: Cold and Hot Wallet Choices and Security Practices
-
9
The Evolution and Challenges of Ethereum: Dencun Upgrade, Vitalik's Vision, and Market Competition Analysis
-
10
ULAB Coin: A Shared Ticker for Multiple Projects - An Analysis of the Current Status and Future Prospects of Unilab, Unchained Lab, and LayerBank
Markets Today
Recommended Reading









